INCLINE VILLAGE, Nev. , Nov. 3, 2016 /PRNewswire/ --  PDL BioPharma, Inc. (PDL or the Company) ( NASDAQ : PDLI) today reported financial results for the third quarter ended September 30, 2016 including: Total revenues of $53.6 million and $177.8 million for the three and nine months ended September

INCLINE VILLAGE, Nev. , Oct. 27, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) ( NASDAQ : PDLI) today announced that the Company will release its third quarter 2016 financial results for the period ended September 30, 2016 , on Thursday, November 3, 2016 , after market close.

INCLINE VILLAGE, Nev. , Aug. 29, 2016 /PRNewswire/ --  PDL BioPharma, Inc. ( NASDAQ : PDLI) (PDL or the Company) today announced that PDL has received approximately $57.4 million in connection with the termination of PDL's credit agreement with Paradigm Spine, LLC , which included a repayment of

INCLINE VILLAGE, Nev. , Aug. 4, 2016 /PRNewswire/ --  PDL BioPharma, Inc. (PDL or the Company) ( NASDAQ : PDLI) today reported financial results for the second quarter ended June 30, 2016 including: Total revenues of $21.0 million and $124.2 million for the three and six months ended June 30, 2016

INCLINE VILLAGE, Nev. , Aug. 4, 2016 /PRNewswire/ --  PDL BioPharma, Inc. ( NASDAQ : PDLI) (PDL or the Company) today announced that its board of directors has decided to eliminate its quarterly cash dividend. John P. McLaughlin , president and chief executive officer of PDL, stated, "Since 2009,

INCLINE VILLAGE, Nev. , Aug. 1, 2016 /PRNewswire/ --  PDL BioPharma, Inc. (PDL or the Company) ( NASDAQ : PDLI) today announced that it has funded the second tranche of $50 million to ARIAD Pharmaceuticals, Inc. (ARIAD) ( NASDAQ : ARIA) which was due on the first anniversary of the closing date

INCLINE VILLAGE, Nev. , July 28, 2016 /PRNewswire/ --  PDL BioPharma, Inc. (PDL or the Company) ( NASDAQ : PDLI) today announced that the Company will release its second quarter 2016 financial results for the period ended June 30, 2016 , on Thursday, August 4, 2016 , after market close.

--Webcast Conference Call Scheduled for Today at 4:30 p.m. EDT--

INCLINE VILLAGE, Nev. , June 13, 2016 /PRNewswire/ --  PDL BioPharma, Inc. (PDL or the Company) ( NASDAQ : PDLI) today announced that it has paid the June 13, 2016 , quarterly dividend payment of $0.05 per share to all stockholders owning shares of PDL as of June 6, 2016 , the record date.

INCLINE VILLAGE, Nev. , June 1, 2016 /PRNewswire/ --  PDL BioPharma, Inc. (PDL) ( NASDAQ : PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, will present at the Jefferies 2016 Healthcare Conference next week in New York .

--Transaction Represents First Specialty Pharmaceutical Transaction by PDL--
--Upon Close, Transaction Expected to be Immediately Accretive--

INCLINE VILLAGE, Nev. , May 4, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) ( NASDAQ : PDLI) today reported financial results for the first quarter ended March 31, 2016 including: Total revenues of $103.1 million for the first quarter of 2016. Non-GAAP diluted earnings per share (EPS) of $0.52

INCLINE VILLAGE, Nev. , May 4, 2016 /PRNewswire/ -- PDL BioPharma, Inc. ( NASDAQ : PDLI) today announced that its board of directors has declared a $0.05 per share dividend for the second quarter of 2016.  The cash dividend will be paid on June 13, 2016 to all stockholders who own shares of PDL on

INCLINE VILLAGE, Nev. , April 28, 2016 /PRNewswire/ --  PDL BioPharma, Inc. (PDL) ( NASDAQ : PDLI) today announced that the Company will release its first quarter 2016 financial results for the period ended March 31, 2016 , on Wednesday, May 4, 2016 , after market close.

INCLINE VILLAGE, Nev. , March 31, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) ( NASDAQ : PDLI) today announced that the Company will hold its annual meeting of stockholders on Thursday, June 2, 2016 , at 10:00 a.m. Pacific Time for all stockholders of record on April 8, 2016 .